| Abbott Labs to Buy Indian Drug Maker Abbott Laboratories will buy Piramal Healthcare's healthcare solutions business for a total of $3.72 billion, boosting its presence in India. online.wsj.com |
The Debt Crisis and the Human Genome Michael Mandel submits:My nomination for the most significant economic event of the past decade: The failure of the Human Genome Project to thus far deliver medically significant results. Let me explain my thinking, and why there may be reason to be guardedly optimistic about the future.Complete Story » seekingalpha.com |
LabCorp Announces $250 Million Stock Repurchase Program (Business Wire) BURLINGTON, N.C.----Laboratory Corporation of America® Holdings today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an additional aggregate of $250 million of its Common Stock from time-to-time. us.rd.yahoo.com |
Good News for Alimera’s Pipeline Zacks.com submits: Recently, Alimera Sciences’ (ALIM) pipeline received a boost when the US Food and Drug Administration ("FDA") accepted the New Drug Application ("NDA") for its lead candidate, Iluvien. Furthermore, the agency has decided to review the application on a priority basis. The company is looking to gain approval for Iluvien for the treatment of diabetic macular edema (DME).The company filed the NDA with the FDA in late June 2010. The US regulatory authority generally reviews those drugs on a priority basis, which offer major advances in treating diseases having no adequate therapy. Applications for priority review designated drugs are reviewed by the FDA within six months of submission instead of the usual ten months. Based on that criterion, a response from the FDA should be out in the fourth quarter of 2010.Complete Story » seekingalpha.com |
GE expands into molecular testing [at Financial Times] - General Electric has agreed to purchase Clarient, a molecular testing company, for about $580m in cash as it seeks to expand into the growing market for products and tests that analyse cancers. us.rd.yahoo.com |